Author

A. Vincent

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

C. MACHON· 2 shared F. CATEZ· 2 shared J. GUITTON· 2 shared J. Pannequin· 2 shared J.-J. DIAZ· 2 shared N. DALLA VENEZIA· 2 shared A. CHOQUET· 1 shared A. DAVID· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. MACHON

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Translational control of cell plasticity drives 5-FU tolerance

M. CHALABI-DCHAR, O. VILLERONCE, J. RIPOLL, A. VINCENT, T. FENOUIL, R. KHOUEIRY, J. KUCHARCZAK, L. JENTSCHEL, F. CATEZ, A. M. Vigneron, J. TREGUIER, C. MANDIER, C. BOUCLIER, J. VITRE, L. LAGERQVIST, , J.-J. DIAZ

The paper shows 5-FU induces translational reprogramming in colorectal cancer cells, enhancing drug tolerance through pro-tumoral gene expression and IL-8 overexpression.

bioRxiv · Jul 3, 2024 · PreprintCancer Biology

Alteration of ribosome function upon 5-fluorouracil treatment favours cancer cell drug-tolerance

G. Therizols, Z. Bash-Imam, B. Panthu, C. Machon, A. Vincent, S. Nait Slimane, M. Garcia, F. Laforets, V. Marcel, J. Boubaker-Vitre, G. Souahlia, M.-A. Albaret, H. C. Mertani, M. Prudhomme, M. Bertrand, , J.-J. Diaz

This study shows that 5-FU treatment creates fluorinated ribosomes that selectively translate survival genes, promoting drug tolerance in cancer cells.

bioRxiv · Jun 4, 2020 · PreprintCancer Biology

Isolation and characterization of rare circulating autoantibody-producing cells from patients with muscle-specific kinase myasthenia gravis

K. Takata, P. Stathopoulos, M. Cao, M. Mane-Damas, M. Fichtner, E. S. Benotti, L. Jacobson, P. Waters, S. R. Irani, P. Martinez-Martinez, D. Beeson, M. Losen, A. Vincent, R. J. Nowak, K. C. O'Connor

The paper isolates and characterizes MuSK-specific autoantibody-producing B cells from MuSK myasthenia gravis patients, generating monoclonal antibodies that reveal distinct binding specificities and functional effects on AChR clustering.

bioRxiv · Dec 13, 2018Immunology